Valeant Pharmaceuticals (VRX) volatility stays elevated after less than expected Q3 and outlook

Valeant Pharma (NYSE: VRX) November weekly call option implied volatility is at 142, November is at 116, December is at 95; compared to its 52-week range of 53 to 173 after reporting less than expected Q3 results and outlook

You May Also Be Interested In

• On Holding AG (ONON) call put ratio 4.5 calls to 1 put with a focus on September 28 and 29 calls
• Pinduoduo (PDD) call put ratio 5.4 calls to 1 put into President Donald Trump and Chinese President Xi Jinping's summit
• XPeng Inc. (XPEV) call put ratio 2.7 calls to 1 put with a focus on October 14 calls